Diarmuid P. O'donoghue

200 Parnell Street, D01 A3Y8
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Impact of the introduction of a new policy of direct faecal immunochemical home screening test provision in a national bowel screening programme, both during and outside of advertising campaigns.

Impact of the introduction of a new policy of direct faecal immunochemical home screening test provision in a national bowel screening programme, both during and outside of advertising campaigns.

Journal: Cancer epidemiology

Published: April 07, 2020

Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Journal: Frontline gastroenterology

Published: January 22, 2020

Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.

Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.

Journal: Clinical and translational gastroenterology

Published: November 20, 2019

Return to bowel screening after a false-positive faecal immunochemical test in BowelScreen (the National Bowel Screening Programme in Ireland).

Return to bowel screening after a false-positive faecal immunochemical test in BowelScreen (the National Bowel Screening Programme in Ireland).

Journal: Journal of medical screening

Published: July 27, 2019

A National Bowel Cancer Screening Programme using FIT: Achievements and Challenges.

A National Bowel Cancer Screening Programme using FIT: Achievements and Challenges.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: May 18, 2018

Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.

Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.

Journal: Gastrointestinal endoscopy

Published: May 13, 2018

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.

Journal: Oncotarget

Published: September 08, 2017

A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening population.

A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening population.

Journal: Frontline gastroenterology

Published: June 07, 2017

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.

Journal: Cancer medicine

Published: November 15, 2016

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.

Journal: Scientific reports

Published: February 08, 2016

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer.

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer.

Journal: BMC cancer

Published: June 19, 2014

Mortality in inflammatory bowel disease patients under 65 years of age.

Mortality in inflammatory bowel disease patients under 65 years of age.

Journal: Scandinavian journal of gastroenterology

Published: April 16, 2014

Showing 1-12 of 23

Last Updated: 09/26/2026